# Immunomodulatory Therapy & VSA

> **NCT06696807** · — · COMPLETED · sponsor: **Dao Wen Wang** · enrollment: 71 (actual)

## Conditions studied

- Vasospastic Angina

## Interventions

- **DRUG:** glucocorticosteroids and/or intravenous immunoglobulin

## Key facts

- **NCT ID:** NCT06696807
- **Lead sponsor:** Dao Wen Wang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06696807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06696807, "Immunomodulatory Therapy & VSA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06696807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*